title: Role of apoptosis in congenital hematologic disorders and bone marrow failure.
abstract: Apoptosis, the cell's intrinsic death program, plays a critical role in the regulation of tissue homeostasis, especially in cell systems with a high turnover rate such as hematopoiesis. Imbalances between survival, proliferation and death of precursor cells or mature cells may result in accelerated loss or impaired output or uncontrolled polyclonal or monoclonal expansion and may pave the way to the development of leukemia. Congenital hematologic disorders are characterized by disturbed growth control of hematopoietic cells. In the previous years, it has become clear that deregulated apoptosis contributes or is even a key determinator of the pathophysiology of diseases such as lymphoproliferation, aplastic anemia or chronic neutropenia. Hematopoietic growth factors have been shown not only to stimulate proliferation of hematopoietic stem cells and committed precursor cells, but also to act as survival factors protecting developing precursor cells from apoptotic signals. The molecular delineation of pathways of apoptosis signaling or survival in hematopoietic cells is expected to provide tools for molecular understanding of the pathophysiology of congenital and acquired hematopoietic disorders and to identify targets for therapeutic intervention strategies.
authors.affiliation: University Children's Hospital, Prittwitzstr. 43, 89075 Ulm, Germany. klaus-michael.debatin@medizin.uni-ulm.de
authors.forename: Klaus-Michael
authors.initials: KM
authors.lastname: Debatin
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D001855:Bone Marrow Diseases / Q000235:genetics / Q000473:pathology*; D006402:Hematologic Diseases / Q000151:congenital / Q000235:genetics / Q000473:pathology*; D006410:Hematopoiesis / Q000502:physiology; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000235:genetics; D015398:Signal Transduction